Assenagon Asset Management
TEVA icon

Assenagon Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Assenagon Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104M Buy
3,056,017
+1,716,315
+128% +$57.2M 0.13% 133
2026
Q1 		$40.4M Sell
1,339,702
-833,046
-38% -$26.8M 0.06% 234
2025
Q4 		$67.8M Sell
2,172,748
-6,155,608
-74% -$152M 0.09% 174
2025
Q3 		$168M Sell
8,328,356
-117,636
-1% -$2.07M 0.23% 87
2025
Q2 		$142M Buy
8,445,992
+2,462,064
+41% +$39.7M 0.21% 99
2025
Q1 		$92M Buy
5,983,928
+4,824,247
+416% +$86.2M 0.15% 118
2024
Q4 		$25.6M Sell
1,159,681
-230,166
-17% -$4.19M 0.04% 315
2024
Q3 		$25M Buy
1,389,847
+985,845
+244% +$17.3M 0.05% 286
2024
Q2 		$6.57M Sell
404,002
-646,697
-62% -$9.96M 0.01% 548
2024
Q1 		$14.8M Buy
1,050,699
+471,137
+81% +$5.94M 0.04% 341
2023
Q4 		$6.05M Buy
579,562
+507,568
+705% +$4.74M 0.02% 579
2023
Q3 		$734K Sell
71,994
-1,768,279
-96% -$16.5M ﹤0.01% 1121
2023
Q2 		$13.9M Buy
+1,840,273
New +$14.9M 0.05% 296
2023
Q1 		– Sell
-1,036,449
Closed -$9.45M – 1509
2022
Q4 		$9.45M Buy
1,036,449
+121,768
+13% +$1.06M 0.03% 392
2022
Q3 		$7.38M Buy
914,681
+381,618
+72% +$3.37M 0.03% 407
2022
Q2 		$4.01M Sell
533,063
-129
-0% -$1.12K 0.01% 612
2022
Q1 		$5.01M Sell
533,192
-1
-0% -$8 0.01% 533
2021
Q4 		$4.27M Buy
533,193
+33,019
+7% +$298K 0.01% 571
2021
Q3 		$4.87M Buy
+500,174
New +$4.68M 0.02% 450

Other funds holding TEVA

UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
RA
Rockingstone Advisors Great Barrington, Massachusetts $249M AUM 31.06% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Assenagon Asset Management's TEVA Position: Q2 2026 in Review

Assenagon Asset Management increased its Teva Pharmaceuticals (TEVA) stake by 128% in Q2 2026, buying an estimated $57.2M and bringing the position to 3,056,017 shares worth $104M. The position accounts for 0.13% of the portfolio, ranked #133.

Assenagon Asset Management first reported a position in TEVA in Q3 2021 and has held it in 19 quarters since. The position peaked at $168M in Q3 2025. 72 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Assenagon Asset Management held 3,056,017 shares of Teva Pharmaceuticals worth $104M as of Q2 2026.
  • Assenagon Asset Management bought 1,716,315 Teva Pharmaceuticals shares in Q2 2026, an estimated $57.2M.
  • Teva Pharmaceuticals made up 0.13% of Assenagon Asset Management's portfolio in Q2 2026, its #133 holding.
  • Assenagon Asset Management first reported a position in Teva Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • Assenagon Asset Management's Teva Pharmaceuticals position peaked at $168M in Q3 2025.
  • 72 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.